High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
26 05 2020
Historique:
received: 13 01 2020
accepted: 08 04 2020
entrez: 19 5 2020
pubmed: 19 5 2020
medline: 15 5 2021
Statut: ppublish

Résumé

Arterial and venous thromboses occur in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein level, and skin changes) syndrome at a previously reported rate of 20%. We reviewed the University College London Hospitals (UCLH) POEMS Registry to determine the rate of venous thromboembolism (VTE), arterial events, and risk factors. This registry, established in 1999 and comprising 103 patients at the time of this study, is the largest single-center cohort in Europe. Of the 83 assessable patients, median age at presentation was 52 years (range, 31-84). Twenty-five patients experienced clinically apparent arterial or venous events, and 2 had concurrent arterial and venous thromboses. Eleven patients had VTEs, including deep vein thrombosis (DVT; 3 of 11), pulmonary embolism (4 of 11), and peripherally inserted central catheter-associated DVT, which occurred during autologous stem cell transplantation (3 of 11). Sixteen patients experienced arterial events: stroke (7 of 16), peripheral arterial occlusion (5 of 16), myocardial infarction (3 of 16), and microvascular disease (1 of 16), with no discernible relationship with thrombocytosis or polycythemia. Thirty percent of POEMS patients have arterial and venous thromboses, higher than previously reported. There were more arterial than venous events, and most occurred during active disease, before the start of chemotherapy, indicating the need for a preemptive approach to thromboprophylaxis.

Identifiants

pubmed: 32421810
pii: S2473-9529(20)31289-1
doi: 10.1182/bloodadvances.2020001492
pmc: PMC7252560
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2139-2142

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 15;5(5):e486
pubmed: 30175160
Curr Opin Neurol. 2018 Oct;31(5):551-558
pubmed: 30138145
J Thromb Thrombolysis. 2008 Apr;25(2):224-6
pubmed: 17514361
Muscle Nerve. 1997 Apr;20(4):486-92
pubmed: 9121507
Medicine (Baltimore). 1996 Jul;75(4):226-32
pubmed: 8699962
Cancer. 2008 Apr 1;112(7):1522-8
pubmed: 18278812
Am J Hematol. 2019 Jul;94(7):812-827
pubmed: 31012139
Neurology. 2009 Oct 20;73(16):1308-12
pubmed: 19841383
J Clin Oncol. 2013 Jun 10;31(17):2189-204
pubmed: 23669224
Leukemia. 2008 Feb;22(2):414-23
pubmed: 18094721

Auteurs

Zara Sayar (Z)

Department of Thrombosis and Hemostasis, University College Hospital, London, United Kingdom.

Anna Weatherill (A)

Department of Thrombosis and Hemostasis, University College Hospital, London, United Kingdom.

Stephen Keddie (S)

Medical Research Council Centre for Neuromuscular Diseases, National Hospital of Neurology and Neurosurgery, and.
Department of Neuromuscular Disease, University College London Institute of Neurology, London, United Kingdom.

Jonathan Sive (J)

Myeloma Service, Cancer Division, University College Hospital, London, United Kingdom.

Michael P Lunn (MP)

Medical Research Council Centre for Neuromuscular Diseases, National Hospital of Neurology and Neurosurgery, and.
Department of Neuromuscular Disease, University College London Institute of Neurology, London, United Kingdom.

Mari Thomas (M)

Department of Thrombosis and Hemostasis, University College Hospital, London, United Kingdom.
Cardiometabolic Biomedical Research Centre, University College London, London, United Kingdom; and.

Shirley D'Sa (S)

Joint POEMS Clinic, Cancer Division, University College Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH